Chief Operating Officer of the Miller School and Uhealth-University Of Miami Health System Dr. Lord currently serves as the Chair of the Board of Directors of Dexcom, as a Director at Stericycle, and serves on advisory boards for Serco PLC (UK), Anthelio Health, and Third Rock Ventures. He has earned certificates in Governance and Audit from Harvard Business School. A nationally recognized leader in innovations in healthcare, Dr. Lord became the University of Miami’s Chief Innovation Officer when he returned to his alma mater in September 2011, after 3 decades in healthcare leadership roles. In March 2012, he was named Chief Operating Officer of the Miller School of Medicine and UHealth-University of Miami Health System. He completed a financial turnaround of the Miller School and continues to serve today as a Professor of Pathology. A board-certified forensic pathologist who began his medical career in the US Navy and later served as Chief Operating Officer of the American Hospital Association and several biotech companies, Dr. Lord served as the CEO for Navigenics, Inc., following his tenure as the former Chief Innovation Officer and senior vice president of Humana. During his time at Humana, he created Humana’s Innovation Center, which combines research, technology, and consumer experience to promote health and well-being.